Medicare Enrolled

Dr. Amy Schefler, M.D.

Ophthalmology · Houston, TX
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
6560 FANNIN ST, Houston, TX 77030
7135243434
Registered in NPPES since 2007
NPI: 1609079367 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Schefler from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Schefler? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Schefler

Dr. Amy Schefler is an ophthalmology specialist in Houston, TX, with 19 years of NPI registration. Based on federal Medicare data, Dr. Schefler performed 12,069 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Schefler received a total of $15,082 from 17 pharmaceutical and/or device companies across 50 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Schefler is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years of NPI registration ▲ Top 9% volume in TX $15,082 industry payments

Medicare Practice Summary — 2023

Medicare Utilization ↗
12,069
Medicare services
Top 9% in TX for ophthalmology
Not available
Unique patients (not deduplicated)
$100
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Eye injection (Vabysmo/faricimab)
An injection of faricimab-svoa, a medication administered in 0.1 mg doses.
6,421 $29 $114
Retinal imaging (OCT scan)
This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye.
1,121 $29 $127
Prolonged office E/M service, first 15 minutes
This code is used for additional time spent by a physician beyond the maximum required time of a primary office or outpatient evaluation and management service. It is billed in 15-minute increments based on total time spent on the date of the primary service.
967 $26 $150
Aflibercept eye injection (Eylea) 720 $690 $2,694
Eye injection for retinal disease
A procedure involving the administration of medication directly into the eye.
564 $100 $474
Comprehensive eye exam, established patient
A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider.
506 $89 $396
Injection, ranibizumab, 0.1 mg 452 $170 $749
Ranibizumab-eqrn injection, 0.1 mg
An injection of the biosimilar medication ranibizumab-eqrn (Cimerli) in a 0.1 mg dose.
260 $214 $824
Ultrasound of eye tissue and structures
A non-invasive imaging test that uses sound waves to create pictures of the eye's internal tissues and structures.
240 $54 $220
Ultrasound of eye tissue and structures
A diagnostic imaging test that uses sound waves to create pictures of the eye's internal tissues and structures.
236 $36 $150
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
186 $139 $561
Ultrasound of eye using water bath method
An ultrasound imaging test of the eye that uses a water bath technique to visualize internal eye structures.
99 $61 $244
Comprehensive eye exam, new patient
A comprehensive examination of the visual system performed for a new patient.
93 $104 $469
Unclassified biologic
A biologic product that does not have a specific HCPCS code assigned.
74 $1,855 $6,946
Eye photography
Photographic imaging of the interior structures of the eye.
34 $16 $148
Retinal photography (fundus photo)
This procedure involves taking photographs of the retina, the light-sensitive tissue at the back of the eye. It is used to document the condition of the eye's interior structures.
23 $27 $118
Fine needle aspiration of orbital contents
A procedure using a thin needle to remove fluid or tissue samples from the area behind the eye for examination.
18 $42 $315
New patient office visit, complex (60-74 min) 18 $175 $689
Retinal growth destruction via radiation implant
A procedure that destroys abnormal retinal growth by implanting a radiation source.
13 $1,139 $4,300
Retinal photocoagulation for vascular growth
This procedure uses laser light to destroy abnormal blood vessels located between the retina and the sclera.
13 $295 $1,645
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
11 $94 $400
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$15,082
Total received (2018-2024)
Avg $2,155/year across 7 years
Top 9% in TX for ophthalmology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
17
Companies
50
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,757
2023
$156
2022
$3,326
2021
$84
2020
$4,341
2019
$3,075
2018
$2,344

Payments by company (2024)

ABBVIE INC.
$1,650
Regeneron Pharmaceuticals, Inc.
$87
Bausch & Lomb Americas Inc.
$20
Top 3 companies account for 100.0% of 2024 payments
All-time payments by company (2018-2024) ›
Regeneron Pharmaceuticals, Inc.
$4,476
Allergan Inc.
$3,866
Bausch & Lomb Americas Inc.
$3,044
ABBVIE INC.
$1,650
OPTOS, INC.
$1,000
Genentech USA, Inc.
$314
Regeneron Healthcare Solutions, Inc.
$187
EyePoint Pharmaceuticals US, Inc.
$135
Genentech, Inc.
$84
Spark Therapeutics, Inc.
$82
AbbVie Inc.
$55
Iridex Corporation
$48
Apellis Pharmaceuticals, Inc.
$42
Allergan, Inc.
$38
Alimera Sciences, Inc.
$22
Vyera Pharmaceuticals, LLC
$21
Novartis Pharmaceuticals Corporation
$19
Top 3 companies account for 75.5% of all-time payments
Associated products mentioned in payments ›
Daraprim Tablet 25mg · EYLEA · EYLEA HD · LUXTURNA · Lucentis · MIEBO · Non-Covered Product · OZURDEX · P200TxE · VYZULTA · Vabysmo · XIPERE · YUTIQ
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for an ophthalmology specialist in Houston?
Compare ophthalmologists in the Houston area by procedure volume, costs, and industry payment transparency.
Browse ophthalmologists nearby

Geographic Context

Ophthalmologists in nearby ZIP areas
298
County median income
$73,104
Nearest hospital to ZIP centroid (approximate)
MEMORIAL HERMANN - TEXAS MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Schefler is a mixed practice specialist, with above-average Medicare volume (top 9% in TX), with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Schefler experienced with eye injection (vabysmo/faricimab)?
Based on Medicare claims data, Dr. Schefler performed 6,421 eye injection (vabysmo/faricimab) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Schefler receive payments from pharmaceutical companies?
Yes. Dr. Schefler received a total of $15,082 from 17 companies across 50 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Schefler's costs compare to other ophthalmologists in Houston?
Dr. Schefler's average Medicare payment per service is $100. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Schefler) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →